ANALYSIS OF HUMAN IMMUNODEFICIENCY VIRUS GLYCOPROTEIN 160 AS A VACCINE CANDIDATE FOR B CELL EPITOPE OF ACQUIRED IMMUNODEFICIENCY SYNDROME (Research Center for Biology-Indonesian Institute of Sciences, 2022)